The North America Vascular Patches Market should witness market growth of 6.4% CAGR during the forecast period (2022-2028).
The market's progress is being greatly aided by the growing amount of R&D activities in the production of vascular patches. An article titled 'Tissue-engineered in-vitro vascular patch fabrication using hybrid 3D printing and electrospinning, ' which was published in the journal Materials.
Today Bio in April 2022, for instance, indicated that cutting-edge hybrid 3D printing biotechnology has the opportunity for widespread use in regenerative medicine and possibly in the prevention of heart disease. The patient-specific vascular patches had an appropriate hemodynamic profile, mechanical characteristics, infiltration of generated vascular smooth muscle cells, survival, and functionality.
Such investigations are likely to accelerate market expansion. The rising demand for vascular patch use throughout hospitals is brought on by the high frequency of stroke and ischemic heart disease, which result in a significant number of hospital admissions. Around the world, many carotid endarterectomies are carried out.
Each year, the United States spends a large portion of its GDP on healthcare. The United States spent roughly 17.8% of its total GDP on healthcare in 2021, according to data on health spending from the Organization for Economic Co-operation and Development (OECD) that was published in 2022. This has sparked regional study and development and raised public awareness of vascular patches.
The US market dominated the North America Vascular Patches Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $144, 833.2 Thousands by 2028. The Canada market is poised to grow at a CAGR of 8.4% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 8.2% during (2022-2028).
Based on Material, the market is segmented into Biologic and Synthetic. Based on End-user, the market is segmented into Hospitals and Ambulatory Surgical Centers. Based on Application, the market is segmented into Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysm, Vascular Bypass Surgery, Congenital Heart Disease and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Edwards Lifesciences Corporation, Baxter International, Inc., Lemaitre Vascular, Inc., Becton, Dickinson and Company, Terumo Corporation, Aziyo Biologics, Inc., Getinge AB, B. Braun Melsungen AG, Artivion, Inc. (CryoLife, Inc.), and W. L. Gore & Associates, Inc.
The market's progress is being greatly aided by the growing amount of R&D activities in the production of vascular patches. An article titled 'Tissue-engineered in-vitro vascular patch fabrication using hybrid 3D printing and electrospinning, ' which was published in the journal Materials.
Today Bio in April 2022, for instance, indicated that cutting-edge hybrid 3D printing biotechnology has the opportunity for widespread use in regenerative medicine and possibly in the prevention of heart disease. The patient-specific vascular patches had an appropriate hemodynamic profile, mechanical characteristics, infiltration of generated vascular smooth muscle cells, survival, and functionality.
Such investigations are likely to accelerate market expansion. The rising demand for vascular patch use throughout hospitals is brought on by the high frequency of stroke and ischemic heart disease, which result in a significant number of hospital admissions. Around the world, many carotid endarterectomies are carried out.
Each year, the United States spends a large portion of its GDP on healthcare. The United States spent roughly 17.8% of its total GDP on healthcare in 2021, according to data on health spending from the Organization for Economic Co-operation and Development (OECD) that was published in 2022. This has sparked regional study and development and raised public awareness of vascular patches.
The US market dominated the North America Vascular Patches Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $144, 833.2 Thousands by 2028. The Canada market is poised to grow at a CAGR of 8.4% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 8.2% during (2022-2028).
Based on Material, the market is segmented into Biologic and Synthetic. Based on End-user, the market is segmented into Hospitals and Ambulatory Surgical Centers. Based on Application, the market is segmented into Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysm, Vascular Bypass Surgery, Congenital Heart Disease and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Edwards Lifesciences Corporation, Baxter International, Inc., Lemaitre Vascular, Inc., Becton, Dickinson and Company, Terumo Corporation, Aziyo Biologics, Inc., Getinge AB, B. Braun Melsungen AG, Artivion, Inc. (CryoLife, Inc.), and W. L. Gore & Associates, Inc.
Scope of the Study
By Material
- Biologic
- Synthetic
By End-user
- Hospitals
- Ambulatory Surgical Centers
By Application
- Carotid Endarterectomy
- Open Repair of Abdominal Aortic Aneurysm
- Vascular Bypass Surgery
- Congenital Heart Disease
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Edwards Lifesciences Corporation
- Baxter International, Inc.
- Lemaitre Vascular, Inc.
- Becton, Dickinson and Company
- Terumo Corporation
- Aziyo Biologics, Inc.
- Getinge AB
- B.Braun Melsungen AG
- Artivion, Inc. (CryoLife, Inc.)
- W.L. Gore & Associates, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Vascular Patches Market, by Material
1.4.2 North America Vascular Patches Market, by End User
1.4.3 North America Vascular Patches Market, by Application
1.4.4 North America Vascular Patches Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Vascular Patches Market
Chapter 4. North America Vascular Patches Market by Material
4.1 North America Biologic Market by Country
4.2 North America Synthetic Market by Country
Chapter 5. North America Vascular Patches Market by End User
5.1 North America Hospitals Market by Country
5.2 North America Ambulatory Surgical Centers Market by Country
Chapter 6. North America Vascular Patches Market by Application
6.1 North America Carotid Endarterectomy Market by Country
6.2 North America Open Repair of Abdominal Aortic Aneurysm Market by Country
6.3 North America Vascular Bypass Surgery Market by Country
6.4 North America Congenital Heart Disease Market by Country
6.5 North America Others Market by Country
Chapter 7. North America Vascular Patches Market by Country
7.1 US Vascular Patches Market
7.1.1 US Vascular Patches Market by Material
7.1.2 US Vascular Patches Market by End User
7.1.3 US Vascular Patches Market by Application
7.2 Canada Vascular Patches Market
7.2.1 Canada Vascular Patches Market by Material
7.2.2 Canada Vascular Patches Market by End User
7.2.3 Canada Vascular Patches Market by Application
7.3 Mexico Vascular Patches Market
7.3.1 Mexico Vascular Patches Market by Material
7.3.2 Mexico Vascular Patches Market by End User
7.3.3 Mexico Vascular Patches Market by Application
7.4 Rest of North America Vascular Patches Market
7.4.1 Rest of North America Vascular Patches Market by Material
7.4.2 Rest of North America Vascular Patches Market by End User
7.4.3 Rest of North America Vascular Patches Market by Application
Chapter 8. Company Profiles
8.1 Edwards Lifesciences Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Acquisition and Mergers:
8.2 Baxter International, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Lemaitre Vascular, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Becton, Dickinson and Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Terumo Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Regional Analysis
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Aziyo Biologics, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.7 Getinge AB
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 B. Braun Melsungen AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.9 Artivion, Inc. (CryoLife, Inc.)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.10. W. L. Gore & Associates, Inc.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Acquisition and Mergers:
Companies Mentioned
- Edwards Lifesciences Corporation
- Baxter International, Inc.
- Lemaitre Vascular, Inc.
- Becton, Dickinson and Company
- Terumo Corporation
- Aziyo Biologics, Inc.
- Getinge AB
- B. Braun Melsungen AG
- Artivion, Inc. (CryoLife, Inc.)
- W. L. Gore & Associates, Inc.
